Search

everythinglearnresearchcommunity

for

Search:↓

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Steroid hormones can be preserved in ancient hair, revealing insights into past health and fertility.

3βHSD2 is not useful for diagnosing PCOS.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Hormone levels change during puberty, leading to physical developments like pubic hair and voice changes.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The treatment helped promote hair growth in men with androgenetic alopecia.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Hirsutism and acne indicate high androgen levels in women with PCOS, and early treatment can improve symptoms and quality of life.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

Family history and elevated DHEA-S levels are linked to more severe hair loss.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

DPP may help hair regrowth by improving blood vessel function under stress.